What is Adeshwar Meditex Ltd (543309) share price return in the past 10 years?

Data is not available for this company

What is the share price of Adeshwar Meditex Ltd (543309)?

Company share prices are keep on changing according to the market conditions. The current trading price of Adeshwar Meditex Ltd (543309) on 06-May-2026 16:59:59 at 16:59 is 16.43.

What is the P/E ratio of Adeshwar Meditex?

The latest standalone P/E ratio of Adeshwar Meditex as of 06-May-2026 is 11.48.

What is the P/B ratio of Adeshwar Meditex Ltd (543309)?

The latest standalone P/B ratio of Adeshwar Meditex Ltd (543309) as of 06-May-2026 is 0.64.

What is the 52-week high and low of Adeshwar Meditex Ltd (543309)?

The 52-week high of Adeshwar Meditex Ltd (543309) is Rs. 21.80 and the 52-week low is Rs. 13.30.

Adeshwar Meditex Ltd (543309) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Adeshwar Meditex Ltd (543309)
Brand: Adeshwar Meditex

Key Metrics

Market Cap

₹24 Cr.

P/E Ratio

11.48

Price to Book (P/B)

0.64

Price to Sales (P/S)

0.28

EV/EBITDA

7.12

Return on Capital Employed (ROCE)

8.53%

Current Price

₹16.4

Return on Equity (ROE)

5.75%

Return on Assets (ROA)

3.04%

Operating Profit Margin

5.3%

Net Profit Margin

2.47%

Gross Profit Margin

3.9%

Book Value per Share

₹25.6

Sales Growth (YoY)

4.83%

Sales Growth (3 Years)

8.93%

Operating Profit Growth (1 Year)

-14.48%

Operating Profit Growth (3 Years)

9.22%

Net Profit Growth (1 Year)

2.99%

52-Week Low / High

₹13 / 22

Net Profit Growth (3 Years)

37.6%

Dividend Yield

0.00%

Promoter Holding

57.68%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Stock return of Adeshwar Meditex Ltd over the last decade?

Over the last 3 year(s), the stock has delivered a CAGR of -13.05% based on the current price.

Q.1 Revenue growth of Adeshwar Meditex Ltd?

Adeshwar Meditex Ltd revenue growth is 4.8% for FY-2025, which is below its 5-year CAGR of 8.33%, indicating slower growth.

Q.1 Which industry/sub-sector does Adeshwar Meditex Ltd belong to?

Adeshwar Meditex Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.1 Promoter shareholding and pledge status of Adeshwar Meditex Ltd?

Promoters hold 57.68% of the Adeshwar Meditex Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Adeshwar Meditex Ltd vs industry peers?

Adeshwar Meditex Ltd revenue CAGR is 8.33%, compared to the industry median CAGR of 8.30%, indicating faster growth and gaining its market share.

DeciZen - make an informed investing decision on Adeshwar Meditex

Based on:

Data

M-Cap below 100cr DeciZen not available

Adeshwar Meditex stock performance

Key Ratios

Is Adeshwar Meditex Ltd an attractive stock to invest in?

1. Is Adeshwar Meditex Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Adeshwar Meditex Ltd is a average quality company.

2. Is Adeshwar Meditex Ltd undervalued or overvalued?

The key valuation ratios of Adeshwar Meditex Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Adeshwar Meditex Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Adeshwar Meditex Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	16.8%	0%	28.8%	17.6%	14.3%	11.1%	7%	10.1%	9.6%	8.5%	-
Value Creation Index ⓘ	0.2	NA	1.1	0.3	0.0	-0.2	-0.5	-0.3	-0.3	-0.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	25.2	0	58.6	52.9	56.1	66	64.8	82.4	79.9	83.7	84
Sales YoY Gr.	-	-100%	NA	-9.7%	6.1%	17.6%	-1.8%	27.2%	-3.1%	4.8%	-
Adj EPS ⓘ	1.5	0	2.6	2.2	2	1.5	0.5	1.4	1.4	1.4	1.4
YoY Gr.	-	-100%	NA	-15.2%	-9.6%	-22.8%	-65.1%	164.2%	0%	1.4%	-
BVPS (₹) ⓘ	8.9	0	13.6	15.9	35.9	19.5	21.5	22.8	24.2	25.6	25.6
Adj Net Profit ⓘ	1	0	2.6	2.2	2.1	1.6	0.8	2	2	2.1	2
Cash Flow from Ops. ⓘ	0	0	-1.2	-5.9	-1	3.2	-2.4	5.8	3.8	3.8	-
Debt/CF from Ops. ⓘ	0	0	-9.9	-3.4	-21.5	7.1	-7.8	2.9	3.6	3.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	14.3%	8.3%	8.9%	4.8%
Adj EPS ⓘ	-0.8%	-6.3%	38.9%	1.4%
BVPSⓘ	12.5%	-6.5%	6.1%	5.9%
Share Price	-	-	-13.1%	2.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	17.9	26.3	14.8	12	8.1	3	6.3	6	5.7	5.6
Op. Profit Mgn % ⓘ	7.5	9.4	7.3	9.8	7.1	5.2	6.3	6.5	5.3	NAN
Net Profit Mgn % ⓘ	4.1	4.4	4.1	3.7	2.4	1.2	2.5	2.5	2.4	2.5
Debt to Equity ⓘ	0.9	0.9	1.3	1.1	1.1	0.6	0.5	0.4	0.3	-
Working Cap Days ⓘ	182	131	238	294	303	356	285	275	273	0
Cash Conv. Cycle ⓘ	83	77	155	174	186	200	153	163	162	0

Recent Performance Summary

Net Profit is growing at healthy rate in last 3 years 38.89%

Return on Equity has declined versus last 3 years average to 5.60%

Sales growth has been subdued in last 3 years 8.93%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	1.4	-
TTM Sales (₹ Cr.)	83.7	-
BVPS (₹) ⓘ	25.6	-
Reserves (₹ Cr.) ⓘ	23	-
P/BV ⓘ	0.64	-
PE ⓘ	11.48	-

From the Market
52 Week Low / High (₹)	13.30 / 21.80
All Time Low / High (₹)	13.30 / 42.00
Market Cap (₹ Cr.)	23.7
Equity (₹ Cr.)	14.4
Face Value (₹)	10
Industry PE ⓘ	44.8

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Adeshwar Meditex - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'14	Mar'15	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	16.28	25.19	58.60	52.92	56.12	65.97	64.76	82.36	79.85	83.71
Operating Expenses ⓘ +	14.47	23.30	53.08	49.04	50.63	61.26	61.36	77.14	74.67	79.29
Manufacturing Costs	1.96	0.96	0	0	2.10	0.81	1.15	1.34	1	0.94
Material Costs	9.97	19.32	47.91	43.67	42.21	54.66	54.89	69.50	69.81	74.42
Employee Cost	1.06	1.43	1.87	2.26	1.17	1.51	1.33	1.33	1.16	1.40
Other Costs ⓘ	1.48	1.60	3.30	3.10	5.15	4.28	3.99	4.97	2.70	2.53
Operating Profit ⓘ	1.82	1.89	5.52	3.88	5.48	4.71	3.40	5.22	5.18	4.43
Operating Profit Margin (%)	11.2%	7.5%	9.4%	7.3%	9.8%	7.1%	5.2%	6.3%	6.5%	5.3%
Other Income ⓘ +	0.12	0.32	0.10	1.82	0.28	0.27	0.23	0.31	0.13	0.26
Exceptional Items ⓘ	0	0	-0	0	0	0	0	0	0	0
Interest ⓘ	0.55	0.57	1.66	2.23	2.52	2.29	2.05	2.09	1.93	1.39
Depreciation ⓘ	0.44	0.38	0.37	0.35	0.34	0.35	0.38	0.53	0.60	0.50
Profit Before Tax ⓘ	0.95	1.25	3.58	3.12	2.91	2.34	1.19	2.90	2.79	2.79
Tax ⓘ	0.37	0.22	1.02	0.87	0.79	0.66	0.40	0.83	0.78	0.73
Profit After Tax	0.58	1.04	2.56	2.25	2.12	1.68	0.79	2.07	2.01	2.07
PAT Margin (%)	3.5%	4.1%	4.4%	4.3%	3.8%	2.5%	1.2%	2.5%	2.5%	2.5%
Adjusted EPS (₹)	0.9	1.6	2.6	2.3	2.0	1.6	0.6	1.4	1.4	1.4
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'14	Mar'15	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	5.50	5.91	13.55	15.80	18.90	20.58	30.95	32.91	34.91	36.96
Share Capital ⓘ	2.85	2.85	4.98	4.98	5.27	10.53	14.43	14.43	14.43	14.43
Reserves ⓘ	2.65	3.06	8.57	10.82	13.64	10.05	16.52	18.48	20.48	22.53
Debt +	4.85	5.44	11.47	19.92	21.32	20.40	17.24	14.52	12.79	11.88
Long Term Debt	2.24	1.67	0.55	5	6.13	5.36	4.07	2.32	1.06	1.94
Short Term Debt	2.60	3.77	10.92	14.92	15.19	15.04	13.17	12.21	11.73	9.94
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	3.14	3.04	5.99	6.85	12.71	17.95	20.83	16.79	14.53	21.21
Others Liabilities ⓘ	2.01	1.58	1.70	1.19	1.79	3.25	3.42	2.67	1.74	1.91
Total Liabilities ⓘ	15.49	15.97	32.71	43.76	54.73	62.17	72.45	66.89	63.96	71.97
Fixed Assets
Net Fixed Assets ⓘ +	3.23	2.62	2.35	2.42	2.28	2.24	3.03	3.70	3.53	2.95
Gross Block	5.55	5.89	6.42	6.85	7.03	7.35	8.53	9.73	10.16	10.01
Accumulated Depreciation	2.32	3.26	4.07	4.42	4.74	5.11	5.50	6.03	6.63	7.05
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	0	0.02	0.04	0.08	0.08	0.10	0.10	0.10	0
Inventories	5.29	4.90	8.46	13.47	14.49	26.11	25.30	24.32	26.53	25.82
Trade Receivables	3.84	4.24	17.45	19.64	27.87	27.26	32.48	27.93	25.27	34.98
Cash Equivalents	0.21	0.25	1.34	1.39	1.73	1.07	1.92	1.90	1.16	2.81
Others Assets ⓘ	2.92	3.96	3.09	6.80	8.27	5.41	9.61	8.93	7.38	5.40
Total Assets ⓘ	15.49	15.97	32.71	43.76	54.73	62.17	72.45	66.89	63.96	71.97

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-1.17	-5.87	-0.99	3.15	-2.44	5.77	3.84	3.80
PBT ⓘ	3.58	3.12	2.91	2.34	1.19	2.90	2.79	2.79
Adjustment ⓘ	1.94	2.44	2.80	2.35	2.28	2.32	2.19	1.60
Changes in Working Capital ⓘ	-5.64	-10.56	-5.88	-0.83	-5.34	1.48	-0.33	0.25
Tax Paid ⓘ	-1.05	-0.88	-0.82	-0.71	-0.56	-0.94	-0.81	-0.84
Cash Flow From Investing Activity ⓘ +	0.07	-0.30	1.58	-0.71	-1.16	-1.16	-0.22	0.51
Capex	-0.01	-0.42	-0.18	-0.32	-1.17	-1.20	-0.43	0.07
Net Investments	-0.02	-0.02	-0.04	-0	-0.02	0	0	0.10
Others ⓘ	0.10	0.14	1.81	-0.38	0.03	0.04	0.21	0.34
Cash Flow From Financing Activity ⓘ +	1.22	6.22	-0.07	-3.11	4.44	-4.62	-4.36	-2.66
Net Proceeds from Shares ⓘ	1.45	0	1	0	9.75	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	1.13	-0.77	-1.29	-1.76	-1.26	0.88
Interest Paid ⓘ	-1.66	-2.23	-2.46	-2.01	-1.91	-1.91	-1.72	-1.16
Dividend Paid ⓘ	0	0	0	0	0	0	0	0
Others ⓘ	1.44	8.45	0.27	-0.32	-2.11	-0.96	-1.39	-2.38
Net Cash Flow ⓘ	0.11	0.05	0.53	-0.66	0.85	-0.02	-0.75	1.65

Finance Ratio

PARTICULARS	Mar'14	Mar'15	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	11.31	18.17	26.33	15.34	12.19	8.5	3.08	6.5	5.92	5.75
ROCE (%)	15.72	16.75	28.76	17.59	14.29	11.13	6.98	10.06	9.6	8.53
Asset Turnover Ratio	1.08	1.6	2.41	1.38	1.14	1.13	0.96	1.18	1.22	1.23
PAT to CFO Conversion(x)	0	0	-0.46	-2.61	-0.47	1.88	-3.09	2.79	1.91	1.84
Working Capital Days
Receivable Days	85.70	58.60	67.60	127.90	154.50	152.50	168.40	133.90	121.60	131.40
Inventory Days	112.90	73.80	41.60	75.60	90.90	112.30	144.90	110	116.20	114.10
Payable Days	130.80	58.50	34.40	53.70	84.60	102.40	128.90	98.80	81.90	87.70

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Adeshwar Meditex Ltd FAQs

The current trading price of Adeshwar Meditex on 06-May-2026 16:59 is ₹16.43.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 05-May-2026 the market cap of Adeshwar Meditex stood at ₹23.71 Cr

The latest P/E ratio of Adeshwar Meditex as of 05-May-2026 is 11.48.

The latest P/B ratio of Adeshwar Meditex as of 05-May-2026 is 0.64.

The 52-week high of Adeshwar Meditex is ₹21.80 and the 52-week low is ₹13.30.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Adeshwar Meditex is ₹83.71 ( Cr.) .

About Adeshwar Meditex Ltd

Adeshwar Meditex is an Indian company, engaged in the manufacturing of surgical dressings and external preparations products of Wound care & Wound management including sterile surgical wound dressing, tulle dressing, medical disposable, adhesive bandages, absorbent gauze, plaster, disinfectants, medical kits etc. The company is an ISO 13485:2016 certified Company. It has manufacturing facility situated at Deewan Industrial Estate, Palghar District. Its state-of-the-art manufacturing plant follows WHO-GMP, CE, ISO guidelines and it is backed by an advanced production facility, which is fitted with latest machinery and well organized and arranged sterilization facilities.

It endeavors to maintain safety in its premises by adhering to key safety norms. Its manufacturing facility also has sophisticated facilities for quality testing, research & development, storage and packaging. It has an in-house R&D facility for on-site process improvement and for bettering its present products offered as well as products under innovation and testing laboratory which ensures that its products are certified and any major defects in the products are identified on real time basis and rectified before the final dispatch. It has dedicated teams actively involved in R&D and QC/ QA Lab activities. These functions have impeccably streamlined and thus assure swift production and post-production processes and enable it to support its growth strategy by developing new products and processes which enhance its product range. The focus of its R&D has been to strive for continuous process improvements which will cater to the requirements of global patients from the point of view of effectiveness and safety besides achieving manufacturing cost efficiencies.

Business area of the company

The company is one of the major, trusted, cGMP, CE, ISO 9001-2008 Certified manufacturer and exporter in the field of sterile surgical wound dressing products and medical disposables.

Major events in the history:

1997: Started business as prop. Concern Adeshwar Meditex.
2007: Incorporation of the Company and subsequently takeover of Proprietorship firm of our promoter Siddharth Talati, Adeshwar Meditex.
2015: The company Crossed turnover of Rs 25 crore.
2018: The company Crossed turnover of Rs 50 crore.
2021: Conversion of Company from “Private Limited” to “Public Limited”.

You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Adeshwar Meditex Ltd (543309) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Adeshwar Meditex Share Price